Be in the know. 14 key reads for Monday…

  1. Regeneron and Gilead Stock Jump as President Trump’s Health Remains in Focus (Barron’s)
  2. The Dirty Secrets Of ‘Clean’ Electric Vehicles (Forbes)
  3. Investors Pile Into U.K. Rental Homes as Covid Hits Young Buyers (Bloomberg)
  4. 9 Dividend Stocks That Can Help Anyone Looking for Income (Barron’s)
  5. Icahn, ex-protege fuel trucking-merge drama (New York Post)
  6. Growth stocks enjoying best year-to-date outperformance since 1979 – but value can soon bounce back, Bank of America says (Business Insider)
  7. Restaurants Prolong Outdoor Dining With Igloos, Heaters (Wall Street Journal)
  8. 3 win Nobel medicine award for hepatitis C virus discovery (MarketWatch)
  9. Abbott exec: Why better COVID-19 tests may help the U.S. get back to normal (MarketWatch)
  10. Charles Schwab Is Quietly One of the Biggest Banks in America. That’s a Problem. (Institutional Investor)
  11. Papa’s Got a Brand New Bag — how James Brown invented funk (Financial Times)
  12. Covid-19 Vaccine Deployment Would Give Global Economy a Lift Next Year (Wall Street Journal)
  13. The Stock Market’s Leaders Appear Most Vulnerable to Biden’s Tax Plan (Wall Street Journal)
  14. Regeneron co-founder on the antibody cocktail Trump is taking to fight coronavirus (FoxNews)

Be in the know. 10 key reads for Sunday…

  1. 8 Best Buffett Stocks to Buy for Dividends (US News)
  2. The Economic Legacy Of Shinzo Abe (NPR Planet Money)
  3. FAANGs Risk Ending Up Like the Nifty Fifty, Cooperman Worries (CIO)
  4. ‘Cobra Kai’ Never Dies With Teaser Video Announcing Season 3 Netflix Premiere Date (Maxim)
  5. Buy Terex Stock. Here’s Why It’s Barron’s Stock Pick This Week. (Barron’s)
  6. Watch Official Trailer for ‘Borat’ Sequel (Maxim)
  7. 2020 Chevrolet Corvette Daily-Driven Review: An Exotic You Can Race Comfortably to Costco (thedrive)
  8. Trump’s illness sparks new urgency for COVID-19 deal (The Hill)
  9. Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works. (TrialSiteNews)
  10. Investors expect banks to kick off better Q3 earnings, but fear stimulus bridge for U.S. economy is crumbling (MarketWatch)

Be in the know. 20 key reads for Saturday…

  1. 7 reasons why investors should favour value stocks over growth, according to BofA (Business Insider)
  2. Wall Street claims the ‘Nasdaq Whale’ is back to pushing up tech stocks (New York Post)
  3. Being Smart is Not Enough (Farnam Street)
  4. Physicians Decided to Start Remdesivir Therapy for Trump (Bloomberg)
  5. JPMorgan’s quant guru details 2 ways Trump’s COVID-19 diagnosis can lift markets (Business Insider)
  6. The Nifty Fifty: Valuing Growth Stocks (Dividend Growth Investor)
  7. Elon Musk: Fusion Will Probably Be More Expensive Than Wind, Solar (Futurism)
  8. Dallas Fed’s Kaplan Lays Out Path for Additional Federal Reserve Aid, If Needed (Wall Street Journal)
  9. Will value survive its long winter? (Robeco)
  10. Warren Buffett’s charity dinner spurred the boss of an online-trading platform to embrace value investing (Business Insider)
  11. Think Like a Poker Player (Real Reutrns)
  12. Monopolies Are Distorting the Stock Market (Sparkline Capital)
  13. Warren Buffett was blasted as ‘washed up’ for not buying during the coronavirus crash. Berkshire Hathaway has announced $19 billion of investments this quarter (Business Insider)
  14. MiB: Dave Portnoy, founder of Barstool Sports (Bloomberg)
  15. What You Need To Know About Trump’s Experimental Coronavirus Antibody Treatment (Forbes)
  16. The Scientologist Billionaire Trying To Make A New Antibiotic (Forbes)
  17. The Richest Hedge Fund Managers On The 2020 Forbes 400 List (Forbes)
  18. Billionaire Backers: Explore The Big Money Behind Biden & Trump (Forbes)
  19. Letter from the Value Investing Mental Asylum or How I Embraced Stoics (Insider Monkey)
  20. ECRI Weekly Leading Index Update (Advisor Perspectives)